Metronomic chemotherapy (MC) in the neoadjuvant setting: Results of two parallel feasibility trials in patients (pts) with HER2 positive (HER2+) and negative (HER2-) locally advanced breast cancer (LABC) (Traq-Me and TAME).
Vanessa Petry
No relevant relationships to disclose
Alessandro Leal
No relevant relationships to disclose
Roberto J. Arai
No relevant relationships to disclose
Simone Marinho
No relevant relationships to disclose
Marcelo Paiva
No relevant relationships to disclose
Jose R. Piato
No relevant relationships to disclose
Marcio Rosa
No relevant relationships to disclose
Paulo M. Hoff
No relevant relationships to disclose
Max S. Mano
No relevant relationships to disclose